Mentoring Translational Research in HIV

Document text

Principal Investigator: David Mitchell Smith
Organization: UNIVERSITY OF CALIFORNIA, SAN DIEGO
Fiscal Year: 2019
Award: $123,468
Funding agency: National Institute of Allergy and Infectious Diseases

Project Summary
This application is a proposed renewal of Dr. Davey Smith's K24 grant entitled `Mentoring Translational Research
in HIV'. This grant supported the training of over 30 trainees and 80 publications to date. While significant
progress in HIV research continues to be made, it is not likely that a safe and effective cure or vaccine for HIV
will be developed soon. The success of these goals will depend on future HIV researchers, many of whom are
likely to be trained in the next five years.
The goal of this K24 proposal is to provide Dr. Smith with sufficient support to mentor trainees in state-of-the-art
translational and patient oriented HIV research and to expand his involvement in UCSD's wide array of training
programs. This application is built upon funded and ongoing research projects, where the mentee is the primary
leader and is trained in every aspect of study design, execution, analyses, results interpretation and publication.
The presented studies provide opportunities for in-depth mentoring as well as investigation into important and
open scientific questions in HIV pathogenesis. These goals will be met in the following three aims with a core
group of junior and senior trainees.
SPECIFIC AIM 1: To determine how co-infections impact HIV pathogenesis.
SPECIFIC AIM 2: To develop and validate new molecular virology technology.
SPECIFIC AIM 3: To use molecular epidemiologic methods to inform HIV prevention.

Terms: <21+ years old><AIDS Virus><AIDS prevention><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Adult><Adult Human><Antibodies><Antibody Repertoire><Award><Blood Sample><Blood specimen><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CDC><CMV><CSIF><CSIF-10><Centers for Disease Control><Centers for Disease Control and Prevention><Centers for Disease Control and Prevention (U.S.)><Chronic><Clinical><Clinical Treatment Moab><Cytokine Synthesis Inhibitory Factor><Cytomegalovirus><DNA><Data><Deoxyribonucleic Acid><Epidemiologic Methods><Epidemiological Methods><Epidemiological Techniques><Funding><Future><Gene Transcription><Genetic Transcription><Goals><Grant><HCMV><HCV><HHV 5><HHV5><HIV><HIV 1 associated neurocognitive disorder><HIV Prevention><HIV vaccine><HIV-1><HIV-1 associated neurocognitive disorder><HIV-I><HIV-associated neurocognitive disorder><HIV/AIDS Vaccines><HIV/AIDS prevention><HIV1><Hepatitis C virus><Human Herpesvirus 5><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><IFN><IL-10><IL10><IL10A><IQ Deficit><IRB><IRBs><Individual><Infection><Institutional Review Boards><Interferons><Interleukin 10 Precursor><Interleukin-10><Investigation><Investigators><LAV-HTLV-III><Length><Lymphadenopathy-Associated Virus><Measures><Mentors><Messenger RNA><Methods><Methods Epidemiology><Molecular><Molecular Epidemiology><Molecular Virology><Monoclonal Antibodies><Neurocognition><Neurocognitive Deficit><New York City><Non-Polyadenylated RNA><Oral><PBMC><PD 1><PD-1><PD1><PD1 gene><Participant><Pathogenesis><Peripheral Blood Mononuclear Cell><Persons><Phylogenetic Analysis><Phylogenetics><Preventative intervention><Prevention intervention><Preventive Intervention><Process><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><RNA><RNA Expression><RNA Gene Products><Regimen><Research><Research Design><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Ribonucleic Acid><Risk><SLEB2 gene><Salivary Gland Viruses><Scientific Publication><Seminal Plasma><Structure><Study Type><T4 Cells><T4 Lymphocytes><Techniques><Technology><Time><Training><Training Programs><Training Support><Transcription><Translational Research><Translational Science><Transmission><United States Centers for Disease Control><United States Centers for Disease Control and Prevention><Viral><Virus-HIV><Work><Writing><adulthood><analysis pipeline><career><clinical database><co-infection><cohort><coinfection><cytomegalovirus group><deep sequencing><human immunodeficiency virus vaccine><improved><mAbs><mRNA><neurocognitive decline><neurocognitive impairment><novel><patient centered><patient oriented><preventional intervention strategy><professor><programmed cell death 1><programmed cell death protein 1><programmed death 1><protocol development><public health intervention><sle2><study design><success><systemic lupus erythematosus susceptibility 2><translation research><transmission process><virology>